Navigation Links
NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term
Date:9/3/2009

how genes are "read" and how they might influence cancer progression. The second is the discovery and validation of predictive biomarkers, chemical signals within the body that provide evidence on the biology of a particular type of cancer and may offer clues for patient prognosis and response to certain therapies. The third is the development of targeted therapeutics, drugs that are specific for particular molecular structures exhibited on the surface of cancer cells.

The SPORE grant primarily funds five main research projects, outlined below, as well as three "core" facilities, which support the research efforts. The core facilities consist of an Administrative Core to oversee research efforts; a Biosample and Tissue Procurement Core to collect and categorize tissue samples for study; and a Biostatistics and Data Management Core to support the researchers ability to analyze the data they collect. The five research projects include:

1. Gene Methylation Signatures for Predictive Classification of Response to Therapy, Co-lead by Fox Chase researchers Paul Cairns, Ph.D., and Mark Morgan, M.D.

Gene methylation (an epigenetic alteration of the genome) of genes related to BRCA1 and BRCA2, may predict how well ovarian cancers respond to particular targeted therapies. Using epigenetic data the SPORE has collected, as well as biosamples from the SPORE repository and national tumor banks, the researchers will test to see how reliably gene methylation predicts sensitivity or resistance to standard and emerging therapies. This could lead to a useful blood test at diagnosis, or at the time of recurrence, of ovarian cancer that could predict the most beneficial therapy and, potentially, a clinical trial of certain targeted therapies that might be able to circumvent the drug resistance.

2. Improving Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 Carriers to Optimize Decision Making, co-lead by Mary Daly, M.D., Ph.D., Fox Ch
'/>"/>

Contact: Greg Lester
gregory.lester@fccc.edu
215-728-2753
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. NCI Renews Mayo Clinic Cancer Center Support Grant, Extends Comprehensive Status
2. NCI renews Mayo Clinic Cancer Center support grant, extends comprehensive status
3. Cardinal Health Renews Distribution Agreement With CVS Caremark
4. The European Association for the Study of the Liver renews publishing partnership with Elsevier
5. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
6. DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm
7. New York Merchants Protective Co. Renews CSAA Five Diamond Certification
8. Specialists On Call Renews Joint Commission Accreditation
9. New book series renews call for ban on gambling
10. Doctor Diabetic Supply, Inc. Renews its ACHC Accreditation
11. American TeleCare, Inc. (ATI) Renews Agreements for its Telehealth Solutions with the Veterans Health Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... first time an oncogenic somatic mutation at amino acid ... been identified in small cell lung cancer (SCLC) tumors ... lines produced increased intracellular signaling and cell growth. , ... representing 15% of all lung cancers and is strongly ... cancer, has been extensively examined for genomic alterations and ...
(Date:8/22/2014)... Paying tuition and other related educational expenses ... for four nurse educators pursuing advanced degrees, thanks to ... Foundation for Nursing Education . This year’s recipients – ... than in 2013, thanks to these named NLN Foundation ... Marcil Endowment Funds, both donated by Kathy Mershon; the ...
(Date:8/22/2014)... New York, New York (PRWEB) August 22, 2014 ... ) continue to be filed in U.S. courts ... cardiovascular events due to their use of prescription ... to court documents, a new claim was filed ... California man who allegedly suffered life-threatening heart issues ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 CarePoint ... specialist in Internal Medicine, Geriatrics, Hospice and Palliative ... CarePoint Health Medical Group. Their system welcomes Dr. ... and experienced physicians comprise CarePoint Health Medical Group, ... in Hudson County, representing a wide range of ...
(Date:8/22/2014)... 2014 (HealthDay News) -- Back-to-school time provides an opportunity ... into the family schedules, an expert suggests. "Forget ... year can also be the start of a new ... professor of kinesiology at the University of the Sciences ... With kids, extracurricular activities likely to build up, "it,s ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:With Kids in School, Parents Can Work Out 2
... Rheumatism (EULAR) welcomes the outcomes of yesterday,s Council of ... 7 December, ministers for health adopted Council Conclusions on ... States and the European Commission to adopt concrete, coordinated ... pleased to note that the Council Conclusions reflect many ...
... (HealthDay News) -- ,Women with localized breast cancer are less ... surgery, a new study finds. The researchers also found ... of the recurrence of localized cancer. The three-nation study ... common type of noninvasive breast cancer, who were followed for ...
... MDA recent study accepted for publication in The Endocrine ... (JCEM) has demonstrated a novel and accurate test for ... in 1,500 to 2,000 female live births and early ... and co-morbid conditions including cardiac and renal problems. ...
... CA (December 8, 2010) People who are neurotic often ... neurotic newlyweds have frequent sexual relations, their marital satisfaction ... counterparts, according to a study in the current ... Neuroticism is the tendency to experience negative ...
... HealthDay Reporter , TUESDAY, Dec. 7 (HealthDay News) -- Stool ... accurate for patients on a low-dose aspirin regimen, which is ... While therapeutic aspirin use was once feared to skew ... researchers found the test was significantly more sensitive for low-dose ...
... can be a life saver for patients needing immediate ... the process of activating them often delays treatment beyond ... print in Annals of Emergency Medicine, was ... multicenter, retrospective chart review, McMullan found that a majority ...
Cached Medicine News:Health News:EULAR welcomes Council action to tackle chronic diseases 2Health News:Radiation After Surgery Lowers Chances of Breast Cancer's Return 2Health News:Frequent sex protects marital happiness for neurotic newlyweds 2Health News:Low-Dose Aspirin Boosts Accuracy of Colon Cancer Test 2Health News:Low-Dose Aspirin Boosts Accuracy of Colon Cancer Test 3Health News:Even with helicopter EMS, hospital transfer can delay treatment for heart attacks 2Health News:Even with helicopter EMS, hospital transfer can delay treatment for heart attacks 3
(Date:8/22/2014)... - On Aug. 20, at its annual meeting in ... (CMA) voted on and approved a delegate resolution opposing ... Bedrocan Cannabis Corp., a leading Canadian licensed producer of ... The CMA is quite right to point out ... plant material, including medicinal cannabis. While some patients, particularly ...
(Date:8/22/2014)... Research and Markets  has announced the addition of ... Technologies" report to their offering. ... you wish to expand your product line, you,ll know ... authors know you want to make effective product development ... improved revenues and take market share from your competition. ...
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2
... 2011 EMKinetics, Inc. announced today initiation of ... trial for patients suffering from urge incontinence and ... at 10-15 US centers.  Submission for CE mark ... the study.   EMKinetics, TranStim therapy builds on ...
... 2011 Masimo (NASDAQ: MASI ) announced ... period ended October 1, 2011, after the market closes on October ... at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted ... de Raad, Executive Vice President and Chief Financial Officer. ...
Cached Medicine Technology:EMKinetics Announces Start of Pivotal Trial for the TranStim™ Transdermal Neuromodulation System 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
Used to introduce large devices for vascular intervention....
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
Medicine Products: